SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-002335
Filing Date
2020-01-29
Accepted
2020-01-29 20:13:27
Documents
1
Period of Report
2020-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3154
  Complete submission text file 0000899243-20-002335.txt   4893
Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210
Business Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210 (617) 951-5372
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (Reporting) CIK: 0001787092 (see all company filings)

State of Incorp.: E9
Type: 3 | Act: 34 | File No.: 001-39200 | Film No.: 20559550